FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from Zydus Lifesciences Limited to market the generic combination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Hypertension

Drugs mentioned

• Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

SUPPL AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)